FDA-Regulated Products Supply Chain Disruptions: Policy Shifts

Navigating the complexities of maintaining a stable supply chain in an ever-changing global environment is a key focus for FDA-regulated companies. As US policy shifts, the topic of global supply chain has only become more complex – and more pressing. So, how can companies address these challenges? And does this affect the availability and safety of essential products? Join us in the first episode of a new series exploring these questions and more.

Questions and Comments: wkirton@bakerlaw.com